Condition
HER2-low Expressing Breast Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 HER2-low Expressing Breast Cancer clinical trials that are recruiting, at sites in 11 countries (most in China (1), Austria (1), Belgium (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 11Countries
All recruiting trials (2)
-
Bevacizumab added or not to T-DXd for HER2-low breast cancer with brain metastases
This trial tests whether adding bevacizumab to trastuzumab deruxtecan helps people with HER2-low breast cancer that has spread to the brain.
-
Observational study on HER2-low breast cancer treatment with Trastuzumab Deruxtecan
This study is testing how well Trastuzumab deruxtecan works for adults with advanced HER2-low breast cancer who have already had chemotherapy.
Related topics
Quick answers
How many HER2-low Expressing Breast Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in China (1 trial), Austria (1 trial), Belgium (1 trial), Denmark (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.